Trials

Phase I and II studies of intravenous sodium SElenite as a cytotoxic agent in advanced CARcinoma of the lung (SECAR)

Cancer type: Lung cancer

Phase: I/II

Principal Investigator: Brodin Ola

Country: SE

Keywords: Sweden, Sodium Selenite, carcinoma

Status: Temporary closed for inclusion